Cook Alan D, Gross Brian W, Osler Turner M, Rittenhouse Katelyn J, Bradburn Eric H, Shackford Steven R, Rogers Frederick B
Trauma Research Program, Chandler Regional Medical Center, Chandler, Arizona.
Trauma and Acute Care Surgery, Penn Medicine Lancaster General Health, Lancaster, Pennsylvania.
JAMA Surg. 2017 Aug 1;152(8):724-732. doi: 10.1001/jamasurg.2017.1018.
Vena cava filter (VCF) placement for pulmonary embolism (PE) prophylaxis in trauma is controversial. Limited research exists detailing trends in VCF use and occurrence of PE over time.
To analyze state and nationwide temporal trends in VCF placement and PE occurrence from 2003 to 2015 using available data sets.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective trauma cohort study was conducted using data from the Pennsylvania Trauma Outcome Study (PTOS) (461 974 patients from 2003 to 2015), the National Trauma Data Bank (NTDB) (5 755 095 patients from 2003 to 2014), and the National (Nationwide) Inpatient Sample (NIS) (24 449 476 patients from 2003 to 2013) databases.
Temporal trends in VCF placement and PE rates, filter type (prophylactic or therapeutic), and established predictors of PE (obesity, pregnancy, cancer, deep vein thrombosis, major procedure, spinal cord paralysis, venous injury, lower extremity fracture, pelvic fracture, central line, intracranial hemorrhage, and blood transfusion). Prophylactic filters were defined as VCFs placed before or without an existing PE, while therapeutic filters were defined as VCFs placed after a PE.
Of the 461 974 patients in PTOS, the mean (SD) age was 47.2 (26.4) and 61.6% (284 621) were men; of the 5 755 095 patients in NTDB, the mean age (SD) was 42.0 (24.3) and 63.7% (3 666 504) were men; and of the 24 449 476 patients in NIS, the mean (SD) age was 58.0 (25.2) and 49.7% (12 160 231) were men. Of patients receiving a filter (11 405 in the PTOS, 71 029 in the NTDB, and 189 957 in the NIS), most were prophylactic VCFs (93.6% in the PTOS, 93.5% in the NTDB, and 93.3% in the NIS). Unadjusted and adjusted temporal trends for the PTOS and NTDB showed initial increases in filter placement followed by significant declines (unadjusted reductions in VCF placement rates, 76.8% in the PTOS and 53.3% in the NTDB). The NIS demonstrated a similar unadjusted trend, with a slight increase and modest decline (22.2%) in VCF placement rates over time; however, adjusted trends showed a slight but significant increase in filter rates. Adjusted PE rates for the PTOS and NTDB showed significant initial increases followed by slight decreases, with limited variation during the declining filter use periods. The NIS showed an initial increase in PE rates followed by a period of stagnation.
Despite a precipitous decline of VCF use in trauma, PE rates remained unchanged during this period. Taking this association into consideration, VCFs may have limited utility in influencing rates of PE. More judicious identification of at-risk patients is warranted to determine individuals who would most benefit from a VCF.
创伤患者中放置下腔静脉滤器(VCF)预防肺栓塞(PE)存在争议。关于VCF使用趋势及随时间推移PE发生率的详细研究有限。
利用现有数据集分析2003年至2015年期间VCF放置及PE发生的州级和全国性时间趋势。
设计、设置和参与者:采用宾夕法尼亚创伤结局研究(PTOS)(2003年至2015年的461974例患者)、国家创伤数据库(NTDB)(2003年至2014年的5755095例患者)和国家(全国)住院患者样本(NIS)(2003年至2013年的24449476例患者)数据库进行一项回顾性创伤队列研究。
VCF放置及PE发生率的时间趋势、滤器类型(预防性或治疗性)以及PE的既定预测因素(肥胖、妊娠、癌症、深静脉血栓形成、大手术、脊髓麻痹、静脉损伤、下肢骨折、骨盆骨折、中心静脉置管、颅内出血和输血)。预防性滤器定义为在存在PE之前或无PE时放置的VCF,而治疗性滤器定义为在PE之后放置的VCF。
PTOS的461974例患者中,平均(标准差)年龄为47.2(26.4)岁,男性占61.6%(284621例);NTDB的5755095例患者中,平均年龄(标准差)为42.0(24.3)岁,男性占63.7%(3666504例);NIS的24449476例患者中,平均(标准差)年龄为58.0(25.2)岁,男性占49.7%(12160231例)。接受滤器的患者(PTOS中有11405例,NTDB中有71029例,NIS中有189957例)中,大多数是预防性VCF(PTOS中占93.6%,NTDB中占93.5%,NIS中占93.3%)。PTOS和NTDB未经调整和调整后的时间趋势显示,滤器放置最初增加,随后显著下降(PTOS中VCF放置率未经调整的降低为76.8%,NTDB中为53.3%)。NIS显示出类似的未经调整趋势,随着时间推移VCF放置率略有增加然后适度下降(22.2%);然而,调整后的趋势显示滤器率略有但显著增加。PTOS和NTDB调整后的PE发生率最初显著增加,随后略有下降,在滤器使用下降期间变化有限。NIS显示PE发生率最初增加随后有一段停滞期。
尽管创伤中VCF使用急剧下降,但在此期间PE发生率保持不变。考虑到这种关联,VCF在影响PE发生率方面的效用可能有限。有必要更明智地识别高危患者,以确定最能从VCF中获益的个体。